Search results for "Anti-inflammatory"

showing 10 items of 671 documents

Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy

2005

The glucocorticoid dexamethasone is frequently used as co-treatment in cytotoxic cancer therapy, e.g. to prevent nausea, to protect normal tissue or for other reasons. While the potent pro-apoptotic properties and the supportive effects of glucocorticoids to tumour therapy in lymphoid cells are well studied, the impact to cytotoxic treatment of colorectal and hepatocellular carcinoma is unknown. We tested apoptosis-induction, viability, tumour growth and protein expression using 8 established cell lines, 18 surgical specimen and a xenograft on nude mice. In the presence of dexamethasone we found strong inhibition of apoptosis in response to 5-FU, cisplatin, gemcitabine or gamma-irradiation,…

OncologyCancer Researchmedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentMice NudeAntineoplastic AgentsApoptosisDexamethasoneMiceGlucocorticoid receptorCell Line TumorInternal medicineCarcinomamedicineAnimalsHumansNeoplasm MetastasisGlucocorticoidsDexamethasoneCisplatinChemotherapybusiness.industryAnti-Inflammatory Agents Non-SteroidalLiver NeoplasmsCancermedicine.diseaseGemcitabineOncologyHepatocellular carcinomaFemaleColorectal NeoplasmsbusinessNeoplasm Transplantationmedicine.drugCancer Letters
researchProduct

Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current trea…

2018

Approved medications for relapsing-remitting multiple sclerosis have shown to be effective in terms of their anti-inflammatory potential. However, it is also crucial to evaluate what long-term effects a patient can expect from current MS drugs in terms of preventing neurodegeneration. Here we aim to provide an overview of the current treatment strategies in MS with a specific focus on potential neuroprotective effects. Areas covered: Randomized, double-blind and placebo or referral-drug controlled phase 2a/b and phase 3 trials were examined; non-blinded phase 4 studies (extension studies) were included to provide long-term data, if not otherwise available. Endpoints considered were expanded…

Oncologymedicine.medical_specialtyAnti-Inflammatory AgentsNeuroimagingDiseaseNeuropsychological TestsPlaceboNeuroprotectionDisability Evaluation03 medical and health scienceschemistry.chemical_compoundMultiple Sclerosis Relapsing-Remitting0302 clinical medicineInternal medicineTeriflunomidemedicineHumansPharmacology (medical)030212 general & internal medicineNeuronsExpanded Disability Status Scalebusiness.industryGeneral NeuroscienceMultiple sclerosismedicine.diseaseMagnetic Resonance ImagingFingolimodNeuroprotective AgentsTreatment OutcomeMultiple sclerosis functional compositechemistryDisease ProgressionNeurology (clinical)businessImmunosuppressive Agents030217 neurology & neurosurgerymedicine.drugExpert Review of Neurotherapeutics
researchProduct

Nopal Cactus (Opuntia ficus-indica) as a Source of Bioactive Compounds for Nutrition, Health and Disease

2014

Opuntia ficus-indica, commonly referred to as prickly pear or nopal cactus, is a dicotyledonous angiosperm plant. It belongs to the Cactaceae family and is characterized by its remarkable adaptation to arid and semi-arid climates in tropical and subtropical regions of the globe. In the last decade, compelling evidence for the nutritional and health benefit potential of this cactus has been provided by academic scientists and private companies. Notably, its rich composition in polyphenols, vitamins, polyunsaturated fatty acids and amino acids has been highlighted through the use of a large panel of extraction methods. The identified natural cactus compounds and derivatives were shown to be e…

Opuntia ficus-indicaOpuntia ficusAnti-Inflammatory AgentsPharmaceutical ScienceDiseaseReviewHealth benefitsBiologyAntioxidantsAnalytical Chemistrylcsh:QD241-441lcsh:Organic chemistryDrug DiscoveryBotanycell signalingAnimalsHumansPhysical and Theoretical Chemistryanti-inflammatorychemistry.chemical_classificationPEARPlant ExtractsOrganic ChemistryOpuntiaPolyphenolschemistryChemistry (miscellaneous)CactusMolecular MedicineExtraction methodsDrug Screening Assays AntitumorPolyunsaturated fatty acidMolecules
researchProduct

Carbonic anhydrase inhibitor with topical NSAID therapy to manage cystoid macular edema in a case of gyrate atrophy

2017

Purpose Gyrate atrophy of the choroid and retina (GACR) is a rare chorioretinal dystrophy characterized by a deficiency of the enzyme ornithine aminotransferase, inherited in an autosomal recessive pattern. Case Report We report a case of a 17-year-old girl with GACR, for whom the level of serum ornithine had been reduced by an arginine-restricted diet. The patient was responsive to an association of topical nonsteroidal anti-inflammatory drugs (NSAIDs) and a carbonic anhydrase inhibitor (CAI) to reduce cystoid macular edema (CME). Conclusions The efficacy of topical NSAIDs and systemic CAI association indicates that the imbalance in the distribution of retinal pigment epithelium membrane-b…

OrnithinePathologygenetic structuresIndomethacinVisual AcuityAdministration OralAdministration Ophthalmic0302 clinical medicineNonsteroidal anti-inflammatory drugCarbonic anhydrase inhibitorCarbonic Anhydrase Inhibitorschemistry.chemical_classificationOrnithine-Oxo-Acid TransaminaseAnti-Inflammatory Agents Non-SteroidalGeneral Medicinemedicine.anatomical_structureDrug Therapy CombinationFemaleTomography Optical CoherenceHumanmedicine.medical_specialtyAdolescentCarbonic Anhydrase Inhibitormedicine.drug_classOrnithine aminotransferaseeducationGyrate atrophy of the choroid and retinaOphthalmic Solution03 medical and health sciencesAtrophyGyrate atrophyInternal medicinemedicineHumansGyrate AtrophyMacular edemaRetinaMacular edemabusiness.industrymedicine.diseaseAcetazolamideOphthalmologyEnzymeEndocrinologychemistry030221 ophthalmology & optometrysense organsChoroidOphthalmic Solutionsbusiness030217 neurology & neurosurgery
researchProduct

Metal complexes of oxadiazole ligands: An overview

2019

Oxadizoles are heterocyclic ring systems that find application in different scientific disciplines, from medicinal chemistry to optoelectronics. Coordination with metals (especially the transition ones) proved to enhance the intrinsic characteristics of these organic ligands and many metal complexes of oxadiazoles showed attractive characteristics for different research fields. In this review, we provide a general overview on different metal complexes and polymers containing oxadiazole moieties, reporting the principal synthetic approaches adopted for their preparation and showing the variety of applications they found in the last 40 years.

OxadizoleAnti-Inflammatory AgentsOxadiazoleAntineoplastic AgentsReviewmetal complexes010402 general chemistryRing (chemistry)01 natural sciencesCatalysisInorganic ChemistryMetallcsh:ChemistryAntineoplastic Agentchemistry.chemical_compoundOrganometallic CompoundsPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyScientific disciplinesGroup 2 organometallic chemistryOrganometallic CompoundOxadiazoles010405 organic chemistryChemistryMetalOrganic ChemistryGeneral MedicineCombinatorial chemistry0104 chemical sciencesComputer Science ApplicationsAnti-Inflammatory Agent124-oxadizolelcsh:Biology (General)lcsh:QD1-999MetalsSettore CHIM/03 - Chimica Generale E Inorganicavisual_artvisual_art.visual_art_mediumMetal complexe134-oxadizole
researchProduct

Anti-inflammatory properties of hydroalcoholic extracts of Argentine Puna plants

2015

The aim of this study is to evaluate the activity of thirteen hydroalcoholic extracts obtained from aerial parts of plants from Argentina Puna on pro-inflammatory enzymes and inflammatory mediators. Eleven extracts were non-cytotoxic on RAW 264.7. Data obtained suggest the capacity of these Argentine Puna plant extracts to inhibit the production of inflammatory mediators (nitric oxide and prostaglandin) at different levels. The plant extracts can affect enzymes expression and/or enzymes activity, and they can also act by NO scavenging. Each extract exerts its anti-inflammatory effect through different mechanisms. The inhibitory ability on pro-inflammatory enzymes by these hydroalcoholic ext…

PUNA PLANT SPECIESNITRIC OXIDE SYNTHASEmedicine.drug_classProstaglandinBiologyAnti-inflammatoryNitric oxideCYCLOOXYGENASE-2Ciencias Biológicaschemistry.chemical_compoundmedicinechemistry.chemical_classificationTraditional medicinePROSTAGLANDINfungifood and beveragesBioquímica y Biología Molecularbiology.organism_classificationEnzyme assayNitric oxide synthaseEnzymechemistryBiochemistryToxicitybiology.proteinArtemia salinaNITRIC OXIDECIENCIAS NATURALES Y EXACTASFood ScienceFood Research International
researchProduct

Pharmacological properties of the methanol extract from Mentha suaveolens Ehrh.

2002

The present study analyses the pharmacological activity in in vivo and in vitro models of the methanol extract obtained from the leaves and steams of Menta suaveolens Ehrh. This extract lacked toxicity, but exhibited a central nervous system depressant action; an analgesic effect in models of chemical and mechanical stimulation suggesting the induction of a peripheral analgesic response. The extract also exhibited an antiinflammatory action inhibiting the rat paw oedema induced by carrageenin. Moreover, the in vitro studies showed a significant diminution in the contractile effects induced by histamine, serotonin and acetylcholine.

PainStimulationPharmacognosyCarrageenanlaw.inventionchemistry.chemical_compoundMicefoodIn vivolawmedicineAnimalsEdemaRats WistarPain MeasurementPharmacologyAnalgesicsTraditional medicinebusiness.industryPlant ExtractsMentha suaveolensAnti-Inflammatory Agents Non-SteroidalBiological activityfood.foodRatsPlant LeaveschemistryFemalePhytotherapybusinessHistamineAcetylcholinemedicine.drugMenthaPhytotherapyPhytotherapy research : PTR
researchProduct

Non-steroidal anti-inflammatory drugs in Parkinson’s disease

2007

Parkinson's disease (PD) is known to be a chronic and progressive neurodegenerative disease caused by a selective degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNc). A large body of experimental evidence indicates that the factors involved in the pathogenesis of this disease are several, occurring inside and outside the DAergic neuron. Recently, the role of the neuron–glia interaction and the inflammatory process, in particular, has been the object of intense study by the research community. It seems to represent a new therapeutic approach opportunity for this neurological disorder. Indeed, it has been demonstrated that the cyclooxygenase type 2 (COX-…

Parkinson's diseaseSubstantia nigraParkinson's DeseaseNeuroprotectionSettore BIO/09 - FisiologiaCyclooxygenase inhibitorschemistry.chemical_compoundDevelopmental NeuroscienceDopamineMedicineHumansNervous system -- DiseasesAgedInflammationHydroxydopaminebusiness.industryPars compactaMPTPDopaminergicAnti-Inflammatory Agents Non-SteroidalParkinson DiseaseParkinson's disease -- TreatmentMiddle Agedmedicine.diseaseNeuroprotective AgentsNeurologychemistrynervous systembusinessNeuroscienceNervous system -- Degenerationmedicine.drug
researchProduct

Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic …

2011

In an earlier work, the role of heat shock protein (Hsp60) in the pathogenesis of ulcerative colitis (UC) was suggested by its significant increase in the pathological mucosa parallel with an increase in inflammatory cells. More data in this direction are reported in this work. We analyzed by immunohistochemistry biopsies of colon tissue from 2 groups of patients with UC and treated with either 5-aminosalicylic acid (5-ASA) alone or in combination with a probiotic. We looked for inflammatory markers and Hsp60. Both the treatments were effective in reducing symptoms but the group treated with both 5-ASA and probiotics showed better clinical results. Amelioration of symptoms was associated wi…

Pathologymedicine.medical_specialtyHistologyColonBiopsyAntigens Differentiation MyelomonocyticInflammationBiomarkers PharmacologicalPathology and Forensic MedicinePathogenesisAntigens CDHeat shock proteinmedicineHumansColitisMesalamineInflammationMucous Membranebusiness.industryCD68ProbioticsAnti-Inflammatory Agents Non-SteroidalColocalizationChaperonin 60medicine.diseaseUlcerative colitisImmunohistochemistryMedical Laboratory TechnologyProtein TransportGene Expression RegulationDisease ProgressionImmunohistochemistryColitis Ulcerativemedicine.symptombusinessFollow-Up StudiesApplied immunohistochemistrymolecular morphology : AIMM
researchProduct

INFLAMMATION IN IRRITABLE BOWEL SYNDROME: MYTH OR NEW TREATMENT TARGET?

2016

Low-grade intestinal inflammation plays a key role in the pathophysiology of irritable bowel syndrome (IBS), and this role is likely to be multifactorial. The aim of this review was to summarize the evidence on the spectrum of mucosal inflammation in IBS, highlighting the relationship of this inflammation to the pathophysiology of IBS and its connection to clinical practice. We carried out a bibliographic search in Medline and the Cochrane Library for the period of January 1966 to December 2014, focusing on publications describing an interaction between inflammation and IBS. Several evidences demonstrate microscopic and molecular abnormalities in IBS patients. Understanding the mechanisms u…

Pathologymedicine.medical_specialtyMEDLINEAnti-Inflammatory AgentsInflammationCochrane LibraryBioinformaticsMast cell03 medical and health sciences0302 clinical medicineTreatment targetsGastrointestinal AgentsIntestinal inflammationmedicinePathologyAnimalsHumansMolecular Targeted TherapyTopic HighlightIntestinal MucosaIrritable bowel syndromeInflammationSettore MED/12 - GastroenterologiaMechanism (biology)business.industrySettore BIO/16 - Anatomia UmanaGastroenterologyGeneral MedicineInflammation; Irritable bowel syndrome; Mast cells; Neuroendocrine cells; Pathologymedicine.diseaseEnteritisClinical trialIrritable bowel syndromeSettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisNeuroendocrine cell030211 gastroenterology & hepatologymedicine.symptomInflammation Mediatorsbusiness
researchProduct